Popescu, Bogdan F.
Frischer, Josa M.
Webb, Samuel M.
Tham, Mylyne
Adiele, Reginald C.
Robinson, Christopher A.
Fitz-Gibbon, Patrick D.
Weigand, Stephen D.
Metz, Imke
Nehzati, Susan
George, Graham N.
Pickering, Ingrid J.
Brück, Wolfgang
Hametner, Simon
Lassmann, Hans
Parisi, Joseph E.
Yong, Guo
Lucchinetti, Claudia F.
Funding for this research was provided by:
Canada Excellence Research Chairs, Government of Canada
Saskatchewan Health Research Foundation
Biogen Idec
National Institutes of Health
Article History
Received: 19 October 2016
Revised: 13 March 2017
Accepted: 14 March 2017
First Online: 22 March 2017
Compliance with ethical standards
:
: This study was funded by the Canada Research Chairs Program (to BFP, GNG and IJP), Saskatchewan Health Research Foundation (to BFP), Biogen Idec (to BFP and CFL), and National Institutes of Health (to CFL). MT, RCA and SN were Fellows of the Canadian Institutes of Health Research Training grant in Health Research Using Synchrotron Techniques (CIHR-THRUST). MT was supported by a College of Medicine Graduate Scholarship, University of Saskatchewan and a Saskatchewan Innovation and Opportunity Scholarship, Government of Saskatchewan.
: Dr. Popescu served as a speaker for Teva Innovation Canada, received honorarium for publishing in Continuum, received research support from the Saskatchewan Health Research Foundation and receives research support from the Canada Research Chairs program and Biogen Idec. Dr. Frischer was supported by the Austrian Science Fund (FWF Project J3508-B24) while conducting parts of this work. Dr. Metz reports grants from German Ministry for Education and Research (BMBF, ‘‘German Competence Network Multiple Sclerosis’’ (KKNMS), Pattern MS/NMO) and BiogenIdec as well as personal fees from BiogenIdec, Bayer Healthcare, TEVA, Serono and Novartis. Dr. Webb, Dr. Robinson, Dr. Adiele, Dr. Weigand, Mr. Fitz-Gibbon, Ms. Tham and Ms. Nehzati report no COI. Dr. Lassmann and Dr. Hametner receive research support from the Austrian Science Foundation and the Österreichische Nationalbank. Drs. George and Pickering receive research support from the Canada Research Chairs program, the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada and from Chevron USA and have received support from the Saskatchewan Health Research Foundation and from Grand Challenges Canada. Dr. Pickering is on the Board of Directors of the Canada Foundation for Innovation and receives additional research support from the Government of Canada. Dr. Brück receives research support from Teva Pharma, Biogen Idec, Novartis, and personal fees from Teva Pharma, Biogen Idec, Novartis, Merck-Serono, Bayer Vital, Genzyme. Dr Parisi receives publishing royalties for <i>Principles & Practice of Neuropathology</i>, Ed 2. Dr. Lucchinetti receives research support from the National MS Society, Novartis, Biogen Idec, and Alexion Pharmaceuticals.